All Webinars Don’t Judge a Body by Its Cover – Body Composition Profiling in Clinical Trials You need a link to access the webinar You will get an access link sent to your e-mail. I agree that AMRA registers the above information and gives me information about services, products etc. via email. Read more about our privacy policy. Body composition profiling in clinical trials – can large scale body composition data enhance the understanding of your study participants? The heterogeneity of disorders such as diabetes type II, coronary heart disease, non-alcoholic fatty liver disease, neuromuscular disorders and obesity is a major problem when evaluating new treatments. A successful treatment for one patient might not be as effective in another. The current paradigms for selecting patients for treatment usually results in a broad spectrum of patient phenotypes, complicating the investigation of treatment efficacy. Magnetic Resonance Imaging (MRI) is regarded as the gold standard for soft-tissue imaging (such as muscles, organs and fat). Lately, large population imaging studies, like the UK Biobank, have enabled the creation of standardized, large-scale reference data sets, allowing for the development of personalized body composition assessment. Body composition profiling is an emerging concept, using large data resources, enabling the investigation of the interplay between different body tissues and compartments and the definition of novel body composition phenotypes. This webinar begins with a short introduction to MRI-based body composition profiling and will thereafter review recent research on the development of novel body composition phenotypes applied in various metabolic and wasting disorders such as sarcopenia. Multiple adipose tissue compartments and their different associations to metabolic disorders will be discussed while highlighting the importance of understanding skewness in body fat distribution. Recent research on how large data sets can be used to enhance the description of the individual and to create personalized virtual control groups to strengthen the interpretation of clinical study data will be presented. WEBINAR DATE 18 June 2020 Jennifer Linge, MSc Lead Scientist, Personalized Medicine AMRA MEDICAL Read more What you will learn • Why measure multiple fat compartments? • How body composition profiling can be used to describe the heterogeneity within metabolic disorders • How large datasets can enhance the description of individuals with sarcopenia-related problems • What a virtual control group is and how it can be used to strengthen the interpretation of clinical study data Who should attend? • Chief Medical Officer • Chief Executive Officer • Principal Investigator • Medical Director • Research Nurse • Clinical Director • Clinical Project Manager • Imaging Specialist • Clinical Operations • Clinical Development Manager • Procurement Manager • Statistician • Data Manager • Regulatory Coordinator • Business Development AMRA Medical is a digital health company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition analysis, delivering multiple fat and muscle biomarkers with unrivaled accuracy and precision – all from a rapid whole-body MRI scan. AMRA offers medical device and medical research services to support transformative care and vital decision-making, from clinical research to clinical care. Contact info@amramedical.com +46 (0) 13 16 26 00 Contact Our Support Follow us Newsletter I agree that AMRA registers the above information and gives me information about services, products etc. via email. Read more about our privacy policy. Data Privacy Policy Cookies © 2021 AMRA MEDICAL AB By using our site, you acknowledge that you have read and understood our privacy policy. We use cookies to ensure you have the best browsing experience on our website. Accept & Close